Skip to content

Avvio named as Ireland’s most innovative supplier at industry awards

Calculus portfolio company Avvio has been recognised as Ireland’s most innovative supplier at the Gold Medal Awards, the leading independent awards programme for the Irish hospitality industry. Furthermore, Tech Ireland has announced that they will be tracking Avvio as an Irish Artificial Intelligence company. This recognises the strength of the technology underpinning the Avvio product, the qualification of … Continued

Calculus Capital host Annual Drinks Reception

On Wednesday 13 September Calculus Capital hosted our Annual Drinks Reception at the In and Out Club, St James’s Square, London. It was well attended by our portfolio companies, with 25 company CEO’s present, as well as members of our adviser and investor community. Ex Conservative Party MP, Brian Binley, delivered a passionate speech about … Continued

Mologic Receives CE Mark Approval for BVPro Point-of-Care Diagnostic for Patients with Bacterial Vaginosis

Mologic Signs Distribution Agreement with Hitado for Germany Bedfordshire, UK, Sept 18th, 2017: Mologic Ltd, which develops powerful, personalised diagnostics to improve the lives of patients, today announced it has received CE mark approval for BVPro®, a rapid point-of-care test for patients presenting with symptoms of vaginosis. The Company also announced the commercial launch of … Continued

Public Vote now open for Growth Champion of the Year Award

Two Calculus portfolio companies have been shortlisted for the Growth Champion of the Year Award at the 2017 Growth Investor Awards. Chop’d and Inspiresport have both been recognised as top-performing SMEs that have best optimised enterprise investment scheme and venture capital funding to scale up their businesses. They have made it to the final eight in their … Continued

Synpromics – new deals signed – new facility opened – new Board member

Edinburgh, UK, 11th September 2017 Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the Roslin Innovation Centre. Synpromics is expanding to meet increasing global demand for its cutting-edge gene control technology, and is the first company to move into the new custom-built centre based at the … Continued